The pharmaceutical industry is undergoing a rapid transformation. With over 60 novel therapeutics approved by the FDA in 2024 and a surge in scientific data, Medical Affairs is now more crucial than ever. This new white paper explores how Medical Affairs functions must evolve to meet the growing demands of scientific rigor, regulatory compliance, and peer-level engagement. As precision medicine an...